leisure time -WSS

leisure time

author：Wikipedia 2025-09-27 09:40:00 - browse：675

Cambridge: Biogen — Ruby Wallau for STAT

Biogen, the iconic but embattled biotech firm, is shuttering Biogen Digital Health, its roughly 150-person group focused on using new types of data like those from mobile phones and smart watches, and ending a clinical trial being conducted with Apple early, STAT has learned.

Biogen confirmed the organizational change, but said it might lean even more on digital tech startups in the future.

“It’s certainly not an abandonment of digital, it’s more of a realignment of resources and priorities,” said Adam Keeney, Biogen’s executive vice president and head of corporate development. However, he later acknowledged, Biogen Digital Health, a separate entity, “would no longer continue in its current form.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Novavax promises a turnaround & Lilly roils the obesity market

WSS

As demand for Covid shots wanes, Moderna seeks its next success

Neuroscience’s long legacy of racism

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Plastic surgeons increase patient psychiatric screenings

Cancer drug shortages should be causing more outrage

Leading voice in opioid treatment defends methadone clinic system

hotspot

leisure time

entertainment

Bright Health sells Medicare Advantage business to Molina

Anesthesiologist group: stop taking Ozempic before surgery

ChatGPT in medicine: STAT answers readers' burning questions

Positive childhood experiences can help future health

The cancer drug shortage isn’t new — and neither are the solutions

Baby aspirin cuts fat buildup in liver disease patients, in small study

Trump demands the U.S. pay no more for drugs than other countries … again

Health AI adoption puts security, privacy startups on investors' radar

Psychedelics group wrestles with new pharma identity

Creating egg and sperm cells from stem cells raises ethical issues

focus

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

U.K. researchers warn about biases in medical devices, algorithms

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Apple is now the first public company to be valued at $3 trillion

SCOTUS questions limit to govt efforts to fight misinformation

At least 13 dead in Texas as scorching temps continue

knowledge

hotspot

focus

entertainment